Remission of Hypertension at Six months of Whole Body Digital Twin Technology.
ViewWhole Body Digital Twin Technology for Remission of T2DM and Improvement in Fatty Liver
ViewWhole Body Digital Twin Technology for Remission of T2DM and Normalization of Glycemic and Fatty Liver Parameters
ViewRemission of Type 2 Diabetes And Regression Of Microalbuminuria With The Whole-Body Digital Twin Technology: A Multicentric, Randomized, Controlled Trial.
ViewCorrelation of Continuous Glucose Monitoring Metrics with HbA1c reduction And Beta Cell Function at one year of Whole-Body Digital Twin Technology for Remission of Diabetes.
ViewImprovement in the Components of Metabolic Syndrome with Remission of T2DM through Whole-body Digital Twin Technology (Abstract)
Concordance between the Various Cardiovascular Risk Scores: Six Months Results of the Randomised Clinical Trial Evaluating Whole-Body Digital Twin Technology Enabled Precision Nutrition for Remission of Diabetes
ViewChange in the sensitometer findings in T2DM undergoing remission: Insights from the one year of Digital Twin Intervention Trial (Abstract)
Quantification of Adiposity, Liver and Pancreas Fat with Magnetic Resonance Imaging in T2DM: Insights From the One Year Of Digital Twin Intervention Trial
ViewCorrelation between the regression of microalbuminuria, Blood pressure reduction and remission of T2DM: Results of Six Month RCCT with Whole-Body Digital Twin Technology
ViewCorrelation Between Remission Of Diabetes And Reductions In Insulin Resistance, Blood Pressure And Cardiovascular Risk Scores: Results Of Six Months Of Randomised Trial With Digital Twin Technology
ViewEffectiveness Of Digital Twin Technology For The Improvement In Depression Among Patients Undergoing Remission Of Diabetes
ViewConcordance between HbA1c, eA1C and fasting plasma glucose criteria to define diabetes remission: Insights from the Initial Six months of Digital Twin Intervention Trial
ViewNormalisation of Glycemic and Extra-Glycemic Parameters with T2DM Remission: Insights from RCT enabled by Whole-Body Digital Twin Technology.
ViewRemission of Type 2 Diabetes and improvement in Metabolic Markers with the Twin Precision Technology (TPT) - A Multicenter, Randomized, Controlled Trial
ViewMetabolic Benefits Beyond Glycemic Control with Artificial Intelligence, Internet of Things and Whole-Body Digital Twin - Initial six months Treatment.
ViewPredictors Of Type 2 Diabetes (T2D) Remission Using Digital Twin Technology Based On Artificial Intelligence (AI) And Internet Of Things (IoT) Technologies.
ViewImpact of Digital Twin technology based on Artificial Intelligence (AI) and Internet of Things (IoT) technologies on diabetes remission and correlation between progressive weight loss with Insulin resistance, waist circumference
Digital Twin Technology For Remission Of Diabetes And Fatty Liver: Initial Results At 6 Months Of Follow up of The Prospective Randomised Controlled Clinical Trial (Abstract).
Association of The Remission of T2DM by Digital Twin Technology with The Improvement In The Glycemic Metrics (Abstract)
ViewRemission of T2DM by Digital Twin Technology Across Indian and American Cohorts- Initial Insights from Real-World Study (Abstract).
ViewGlycemic Control with Improvement in HOMA2 IR and HOMA2 Beta: Impact of Digital Twin Enabled Precision Nutrition for Remission of Diabetes(Abstract)
ViewWhole Body Digital Twin Technology for Reversal of Chronic Diseases with Simultaneous Benefits to Reduce the Burden of Cardiovascular Disease (Abstract)
Effect Of Digital Twin Technology For Remission Of Diabetes On The Glycemic And Extra Glycemic Parameters : Interim Results Of The Prospective Randomised Controlled Clinical Trial (Abstract).
ViewHealth Economic Analysis of Digital Twin Technology for Remission of Diabetes - Initial Insights from the Prospective Randomised Controlled Clinical Trial (Abstract).
ViewInitial Insights For The Changes In The Cardiometabolic Parameters Using The Twin Technology Enabled Precision Nutrition (Abstract).
ViewDigital Twin Enabled Precision Nutrition Induces Remission of Diabetes Independent of Improvement in the Markers of Obesity (Abstract).
ViewRelationship between Renal Function and Glycemic Changes in Type 2 Diabetes Mellitus: Initial Insights from the Randomised Trial Evaluating Whole-Body Digital Twin Technology .
Relationship between Obesity, Insulin Resistance and Glycemic Changes in Type 2 Diabetes Mellitus: Initial Insights from the Randomised Trial Evaluating Whole-Body Digital Twin Technology Enabled Precision Nutrition for Reversal of Diabetes (Abstract)
ViewResponse to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 weeks (Abstract)
ViewCombined Improvement of Insulin Resistance and Hypertension Using Whole Body Digital Twin Technology in Diabetic Hypertensives- A Real World Study (Abstract)
ViewCorrelation between the Glycated Hemoglobin and HOMA indices in Type 2 Diabetes Mellitus: Impact of Whole-Body Digital Twin Technology enabled Precision Nutrition (Abstract).
Digital Twin Technology Intervention To Achieve And Maintain The Glycemic Variability Within The Targets In T2DM– Insights From Real World Study (Abstract).
ViewMetabolic Benefits Beyond Glycemic Control with Improvement in Insulin Resistance and Testosterone: Impact of Twin Enabled Precision Nutrition (Abstract).
ViewUtilising Internet of Things and Artificial Intelligence to Enable Twin Precision Treatment for Reversal of Type 2 Diabetes (Abstract)
ViewType 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study 7, 21 (2021).
ViewRetrospective Study of Glycemic Variability, BMI, and Blood Pressure in Diabetes Patients in the Digital Twin Precision Treatment Program, 11, 14892 (2021)
ViewReducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-enabled Twin Precision Treatment: A Retrospective Analysis. Diabetes Therapy, 2020 Nov;11(11):2703-14.
ViewRemission of T2DM by Digital Twin Technology with Reduction of Cardiovascular Risk: Interim Results of Randomised Controlled Clinical Trial (Abstract).
View